Posterior Reversible Encephalopathy Syndrome Associated with FOLFOX Chemotherapy

Posterior reversible encephalopathy syndrome (PRES) is a clinicoradiologic entity characterized by headaches, altered mental status, seizures, visual loss, and characteristic imaging pattern in brain MRI. The cause of PRES is not yet understood. We report a case of a 27-year-old woman that developed...

Full description

Bibliographic Details
Main Authors: Luiz Carlos Porcello Marrone, Bianca Fontana Marrone, Tharick Ali Pascoal, Lucas Porcello Schilling, Ricardo Bernardi Soder, Sheila Schuch Ferreira, Giovani Gadonski, Jaderson Costa da Costa
Format: Article
Language:English
Published: Hindawi Limited 2013-01-01
Series:Case Reports in Oncological Medicine
Online Access:http://dx.doi.org/10.1155/2013/306983
id doaj-42aefd70481a471e9953bdac8e97be99
record_format Article
spelling doaj-42aefd70481a471e9953bdac8e97be992020-11-24T23:16:38ZengHindawi LimitedCase Reports in Oncological Medicine2090-67062090-67142013-01-01201310.1155/2013/306983306983Posterior Reversible Encephalopathy Syndrome Associated with FOLFOX ChemotherapyLuiz Carlos Porcello Marrone0Bianca Fontana Marrone1Tharick Ali Pascoal2Lucas Porcello Schilling3Ricardo Bernardi Soder4Sheila Schuch Ferreira5Giovani Gadonski6Jaderson Costa da Costa7Hospital São Lucas/Instituto do Cérebro (Inscer), Pontificia Universidade Católica do Rio Grande do Sul (PUCRS), Avenida Ipiranga 6690, 90610-000 Porto Alegre, RS, BrazilHospital São Lucas/Instituto do Cérebro (Inscer), Pontificia Universidade Católica do Rio Grande do Sul (PUCRS), Avenida Ipiranga 6690, 90610-000 Porto Alegre, RS, BrazilHospital São Lucas/Instituto do Cérebro (Inscer), Pontificia Universidade Católica do Rio Grande do Sul (PUCRS), Avenida Ipiranga 6690, 90610-000 Porto Alegre, RS, BrazilHospital São Lucas/Instituto do Cérebro (Inscer), Pontificia Universidade Católica do Rio Grande do Sul (PUCRS), Avenida Ipiranga 6690, 90610-000 Porto Alegre, RS, BrazilHospital São Lucas/Instituto do Cérebro (Inscer), Pontificia Universidade Católica do Rio Grande do Sul (PUCRS), Avenida Ipiranga 6690, 90610-000 Porto Alegre, RS, BrazilHospital São Lucas/Instituto do Cérebro (Inscer), Pontificia Universidade Católica do Rio Grande do Sul (PUCRS), Avenida Ipiranga 6690, 90610-000 Porto Alegre, RS, BrazilHospital São Lucas/Instituto do Cérebro (Inscer), Pontificia Universidade Católica do Rio Grande do Sul (PUCRS), Avenida Ipiranga 6690, 90610-000 Porto Alegre, RS, BrazilHospital São Lucas/Instituto do Cérebro (Inscer), Pontificia Universidade Católica do Rio Grande do Sul (PUCRS), Avenida Ipiranga 6690, 90610-000 Porto Alegre, RS, BrazilPosterior reversible encephalopathy syndrome (PRES) is a clinicoradiologic entity characterized by headaches, altered mental status, seizures, visual loss, and characteristic imaging pattern in brain MRI. The cause of PRES is not yet understood. We report a case of a 27-year-old woman that developed PRES after the use of FOLFOX 5 (oxaliplatin/5-Fluoracil/Leucovorin) chemotherapy for a colorectal cancer.http://dx.doi.org/10.1155/2013/306983
collection DOAJ
language English
format Article
sources DOAJ
author Luiz Carlos Porcello Marrone
Bianca Fontana Marrone
Tharick Ali Pascoal
Lucas Porcello Schilling
Ricardo Bernardi Soder
Sheila Schuch Ferreira
Giovani Gadonski
Jaderson Costa da Costa
spellingShingle Luiz Carlos Porcello Marrone
Bianca Fontana Marrone
Tharick Ali Pascoal
Lucas Porcello Schilling
Ricardo Bernardi Soder
Sheila Schuch Ferreira
Giovani Gadonski
Jaderson Costa da Costa
Posterior Reversible Encephalopathy Syndrome Associated with FOLFOX Chemotherapy
Case Reports in Oncological Medicine
author_facet Luiz Carlos Porcello Marrone
Bianca Fontana Marrone
Tharick Ali Pascoal
Lucas Porcello Schilling
Ricardo Bernardi Soder
Sheila Schuch Ferreira
Giovani Gadonski
Jaderson Costa da Costa
author_sort Luiz Carlos Porcello Marrone
title Posterior Reversible Encephalopathy Syndrome Associated with FOLFOX Chemotherapy
title_short Posterior Reversible Encephalopathy Syndrome Associated with FOLFOX Chemotherapy
title_full Posterior Reversible Encephalopathy Syndrome Associated with FOLFOX Chemotherapy
title_fullStr Posterior Reversible Encephalopathy Syndrome Associated with FOLFOX Chemotherapy
title_full_unstemmed Posterior Reversible Encephalopathy Syndrome Associated with FOLFOX Chemotherapy
title_sort posterior reversible encephalopathy syndrome associated with folfox chemotherapy
publisher Hindawi Limited
series Case Reports in Oncological Medicine
issn 2090-6706
2090-6714
publishDate 2013-01-01
description Posterior reversible encephalopathy syndrome (PRES) is a clinicoradiologic entity characterized by headaches, altered mental status, seizures, visual loss, and characteristic imaging pattern in brain MRI. The cause of PRES is not yet understood. We report a case of a 27-year-old woman that developed PRES after the use of FOLFOX 5 (oxaliplatin/5-Fluoracil/Leucovorin) chemotherapy for a colorectal cancer.
url http://dx.doi.org/10.1155/2013/306983
work_keys_str_mv AT luizcarlosporcellomarrone posteriorreversibleencephalopathysyndromeassociatedwithfolfoxchemotherapy
AT biancafontanamarrone posteriorreversibleencephalopathysyndromeassociatedwithfolfoxchemotherapy
AT tharickalipascoal posteriorreversibleencephalopathysyndromeassociatedwithfolfoxchemotherapy
AT lucasporcelloschilling posteriorreversibleencephalopathysyndromeassociatedwithfolfoxchemotherapy
AT ricardobernardisoder posteriorreversibleencephalopathysyndromeassociatedwithfolfoxchemotherapy
AT sheilaschuchferreira posteriorreversibleencephalopathysyndromeassociatedwithfolfoxchemotherapy
AT giovanigadonski posteriorreversibleencephalopathysyndromeassociatedwithfolfoxchemotherapy
AT jadersoncostadacosta posteriorreversibleencephalopathysyndromeassociatedwithfolfoxchemotherapy
_version_ 1725586599550386176